Our firm represented InterCure in a private placement, in which it raised $12 M from Alex Rabinovich, the controlling shareholder of the Company, and Gary Fegel, the founder of GMF Capital.
InterCure is a public company traded on the Tel Aviv Stock Exchange and is the controlling shareholder of Canndoc, which has been involved in the research, cultivation, growth and marketing of medical cannabis over the past decade.
The proceeds of the transaction will be used by the Company to implement its objectives and business strategy in the field of medical cannabis.
InterCure was represented by Advs. Udi Knaani and Orely Levy.
For the full coverage click here>>